Bob Cohen, CDT · June 6, 2012
Hi, Being a reseller of CAD CAM equipment we have found it to be very interesting that many decision makers in dental labs want help figuring out if it's the right time to buy. From a business perspective...See more it's all about return on investment (ROI). So, for the sake of this exercise let's look at the cost of borrowing $10K over 5 years. Based on 21 manufacturing days in a month the $10K turns out to cost about $8.50 per day. So, a $27K scanner will run a little less than $25 per day. That said, if you are outsourcing models and the model base work flow is costing $25 more than just sending a digital file for manufacturing you can logically see that it does not take much work to get to a break even or to become significantly more profitable. In addition, you need to add in the labor to scan and design the cases in your facility. This cost can very widely with efficiency of the individual(s) performing this operation. On the other side of the coin, you gain the savings of the cost of packaging and shipping (in addition to time savings). In reality, these two costs may be close to equal, so, it's a wash. In conclusion, labs outsourcing 20 plus units a month are at the break even point to purchase a scanner and CAD software that is in the cost range of about $27K. In conclusion, one can figure a daily cost of about $8.50 per $10K borrower over 5 years. Hope this post can help some of those in question. Please feel free to add comments. Bob
Laura Sheppard, CDT/TE · May 18, 2012
The NBC has been asked for CAD CAM credentialling. I know it sounds good on paper. But practically, how would you envision a CAD CAM test to be, that would credential this skill set? What would we test...See more candidates on (designing?), how would we evaluate it and what tools would be required? Keeping in mind that each test facility would likely need to have the process(s) on site? Or, would each candidate bring a lap top with software? would there be a production element? Also, the industry does not have one universal open-architect system that all candidates would have access to, or be trained on. And, non-vendor specific training materials need to be available......any and all ideas are welcome. :)
exocad GmbH is now integrated with 3M®/Steinbichler® and Renishaw® scanners; labs that own these systems can upgrade to an exocad-based system for only the cost of the software. In addition,...See more exocad has a new touch-enabled user interface, compatible with Windows 8 devices. An enhancement to the TruSmile® add-on module allows realistic per-tooth rendering for different metal alloys and ceramics, providing the dentist with a valuable tool to increase patient acceptance of a proposed restorative design. Note to any Lab Day Chicago attendees who tried to attend exocad’s clinics, Why is Everyone Talking About exocad?: Options from your Current CAD/CAM System and For Advanced and Experienced exocad Users, between 1:00-3:00pm on Saturday: these clinics were actually presented earlier in the day; there was a misprint in the Show Program Guide. As a consideration to those attendees, exocad is offering a free full-day training session on June 14 at exocad’s test lab in Boston, MA. Attendees must pay for their own travel and lodging, but the training, meals and fun will be provided. For more information, call 855-EXO-4CAD (386-4223), email firstname.lastname@example.org or visit www.exocad.com.
Jensen Dental announced two enhancements to the Preciso Digital Dentistry Solution: All Preciso configurations with Preciso CAD Software now have the ability to export .stl files. Using a patent-pending...See more fixture, users of the Preciso M200 mill can easily switch from milling frameworks in the traditional 3M™ ESPE™ Lava™ material form to milling 98-mm pucks. Customers who purchase an M200 Frame Mill—the frame version of the Preciso M200—also have the option to upgrade to a puck fixture at any time. “As digital dentistry continues to evolve, our goal is to empower our customers to customize a solution that suits the needs of their lab and their doctors. Although our current customers can mill the vast majority of their restorations using our frame mills which start as low as $14,995, we now offer the flexibility of both a fully validated [with 3M ESPE Lava materials, Jensen’s XT and HT zirconia, Jensen Wax and Jensen PMMA] and fully open system, all at unprecedented prices,” said Joseph Carofano, General Manager of Jensen Dental. Visit www.PrecisoDental.com or call 800-243-2000.
Global Dental Science (GDS), makers of AvaDent Digital Dentures™, has entered into a long-term strategic partnership with Dental Wings: All DWOS 7 iSeries scanners are able to send files directly...See more to GDS. Dental Wings is adding GDS software on all of its scanners. Dental Wings scanner owners who are not currently AvaDent customers now have an option in the DWOS Connect™ network to send files to GDS to create an AvaDent denture. “The partnership with Dental Wings will be extremely valuable in helping us accelerate the adoption of our digital denture workflow into the dental laboratory market,” said Tim Thompson, CEO of Global Dental Science. Dental Wings CEO Naoum Araj stated, “We have been highly impressed with the AvaDent team and their technology, so we are extremely pleased to be able to help them achieve their objectives in moving denture fabrication into the digital age.” For more information, visit www.AvaDent.com or www.dentalwings.com or send an email to KentWilliams@GlobalDentalScience.
Previously sold only in Japan, Shofu Dental’s EyeSpecial C-II digital camera is now available in the U.S. Designed exclusively for dentistry and ideal for use in the laboratory, the camera features...See more 12 megapixels, eight shooting modes, 49-mm close-up lens, intuitive one-touch operations, and a large LCD touchscreen that allows the user to view and scroll through images even with a gloved hand. The EyeSpecial C-II has excellent depth of field range, fast autofocusing and anti-shake capabilities, as well as infrared, UV and anti-reflection filters. It’s lightweight and can be held comfortably with one hand and comes with a 4GB SD XC card. It is also compatible with an Eye-Fi Pro X2 card, allowing images to be automatically transferred and uploaded onto a computer, tablet or smartphone. The EyeSpecial C-II comes with SureFile photo management software, available for free download, that allows the user to automatically sort and file images by patient name or ID number, saving time and improving compliance to HIPAA standards. For more information, call 800-827-4638 or visit www.shofu.com.
Roland DGA Corp. introduced two new optional accessories for the company’s DWX-4 compact mill: An automatic tool changer (ATC) that supports up to four different tool sizes for highly precise unattended...See more milling. A multi-pin clamp that allows the machine to mill up to four different pin-type materials simultaneously, accommodating differences in material composition and color. As a result, prosthetics for up to four different patients can be produced in a single production run, saving time, labor and costs. “The DWX-4 is an easy-to-use, precise, on-demand production platform for digital dentistry,” said Brian Brooks, Product Manager for Roland. “These new tools enhance the DWX-4 by both expediting and automating production for more complex jobs.” Measuring 13” x 14” x 16”, the DWX-4 supports a variety of materials, including 3M ESPE’s Lava™ Ultimate Restorative, zirconia, PMMA and wax. Open architecture by design, it integrates seamlessly into an existing workflow and also comes with Roland EasyShape CAM software. In addition, an enhanced ROI calculator is now available on the Roland website for both the DWX-4 and the DWX-50. For more information, call 800-542-2307 or visit www.rolanddga.com.
Ivoclar Vivadent Inc. · Apr 28-29 · Troy, MI
Ivoclar Vivadent Inc. · May 5-6 · Canoga Park, CA
Ivoclar Vivadent Inc. · May 12-13 · Mississauga, ON
National Dentex Corporation (“NDX”) announces the acquisition of nSequence Center for Advanced Dentistry (“nSequence”) based in Reno, NV. nSequence (www.nsequence.com) is a state...See more of the art full service digital and conventional dental laboratory that specializes in CT guided surgery and guided prosthetics. nSequence was founded and operated by Daniel Llop, CDT. “We are excited to have nSequence join NDX. nSequence uses technology to take into account treatment techniques, implant systems, physiology of the patient, and aesthetics when planning a case. Innovation at nSequence has been driven by Daniel Llop, CDT who understands the goals of the surgical and restorative team, as well as the capabilities of an experienced dental technician, and the awesome potential of technology in virtual case planning,” commented Steven Casper, NDX Chief Executive Officer. nSequence brings to the market broad surgical and prosthetic guidance capability. While they can accept treatment plans for all guided surgery systems and software on the market today, they have also developed their own FDA 510k cleared proprietary system called Maven Pro. Maven Pro is a comprehensive implant and prosthetic planning software that can display surgical and restorative options and allows for live web collaboration between the physician, the dental technician, and in some circumstances the patient, before gaining case acceptance and determining the case plan. “In the exciting field of pre-operative virtual guided surgery and prosthetic planning I realized an opportunity to increase insight and understanding of a patient’s anatomy, surgical and prosthetic options and approaches before a scalpel or drill was used. The creation of the virtual patient has taken the dental professional to a new level of communication with their peers and patients. With fewer office visits, chair time, increased accuracy and lower costs associated with the treatment, the patient has clearly been the main benefactor. I am so pleased that NDX shares our vision of the future of CT guided surgery and the expanding role of the dental lab and the technician,” commented Daniel Llop. Daniel Llop will continue to run day to day operations at nSequence and joins the NDX leadership team as the Director of CT Guided Implant Technology.
EPS up 13.5% to $1.43 Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial...See more results for the quarter ended December 28, 2013. Net sales for the fourth quarter of 2013 were $2.5 billion, an increase of 4.9% compared with the fourth quarter of 2012. This consisted of 4.4% growth in local currencies and 0.5% growth related to foreign currency exchange. In local currencies, internally generated sales increased 3.7% and acquisition growth was 0.7% (see Exhibit A for details of sales growth). Net income attributable to Henry Schein, Inc. for the fourth quarter of 2013 was $124.3 million or $1.43 per diluted share, an increase of 10.5% and 13.5%, respectively, compared with the fourth quarter of 2012. "We are pleased to complete a very successful 2013 with strong fourth quarter results," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Sales growth during the fourth quarter was solid and on plan. Importantly, we believe we gained market share in each of our four global business units and exceeded the top of our original EPS guidance range for the year." Global Dental sales of $1.4 billion increased 3.9%, consisting of 3.1% growth in local currencies and 0.8% growth related to foreign currency exchange. In local currencies, internally generated sales increased 2.6% and acquisition growth was 0.5%. The 2.6% internal growth in local currencies included 2.1% growth in North America and 3.5% growth in International. "Gains in North America Dental sales included solid growth in consumable merchandise, while equipment sales and service revenue declined slightly following growth of nearly 22% in the prior-year quarter, making for a challenging comparison," commented Mr. Bergman. "International Dental returned to growth during the quarter as consumable merchandise posted positive gains and equipment sales and service revenue growth accelerated from the previous quarter." Global Animal Health sales of $651.7 million increased 6.6%; there was no material impact on sales growth from foreign currency exchange. Internally generated sales increased 4.8% and acquisition growth was 1.8%. The 4.8% internal growth in local currencies included 7.0% growth in North America and 2.9% growth in International. "Once again our Global Animal Health business performed well during the quarter. North America internal sales growth in the high single digits is consistent with our stated goals, and International Animal Health internal sales growth in local currencies accelerated slightly versus the prior quarter," commented Mr. Bergman. Global Medical sales of $421.9 million increased 4.8%, including 4.6% growth in local currencies and 0.2% growth related to foreign currency exchange. "Reported Global Medical growth benefitted from higher sales of seasonal influenza vaccines versus the prior year. Excluding this impact, our Global Medical sales growth accelerated slightly compared to the third quarter. We believe patient traffic to U.S. physician offices was largely consistent with the prior quarter," remarked Mr. Bergman. "We are confident that our focus on large group practices will allow us to continue to gain market share." Global Technology and Value-Added Services sales of $88.4 million increased 8.6%, including 8.9% growth in local currencies and a 0.3% decline related to foreign currency exchange. In local currencies, internally generated sales increased 8.6% and acquisition growth was 0.3%. "Technology and Value-Added Services growth was driven by electronic services recurring revenue, software sales and value-added services," commented Mr. Bergman. "Sales in International markets were particularly strong." Stock Repurchase Plan The Company announced that it repurchased approximately 664,000 shares of its common stock during the fourth quarter at an average price of $111.04 per share, or approximately $73.8 million. The impact of the repurchase of shares on fourth quarter diluted EPS was immaterial. For the full year 2013 the Company repurchased $300.3 million in stock, representing 3.1 million shares at an average price of $97.71 per share, which is in line with our stated goals. At the close of the fourth quarter, Henry Schein had approximately $300 million authorized for future repurchases of its common stock. Full-Year Results For 2013, net sales of $9.6 billion increased 6.9% compared with 2012. This consisted of 6.8% growth in local currencies and 0.1% growth related to foreign currency exchange. In local currencies, internally generated sales increased 3.6% and acquisition growth was 3.2%. Net income attributable to Henry Schein, Inc. for 2013 was $431.6 million or $4.93 per diluted share. Excluding certain one-time items, adjusted net income attributable to Henry Schein, Inc. for 2013 was $433.4 million or $4.95 per diluted share, an increase of 8.7% and 11.5%, respectively, compared with adjusted net income for 2012 (see Exhibit B for reconciliation of GAAP net income and EPS to non-GAAP adjusted net income and EPS). 2014 EPS Guidance Henry Schein today affirmed 2014 financial guidance, as follows: For 2014 the Company expects diluted EPS attributable to Henry Schein, Inc. to be $5.29 to $5.39, which represents growth of 7% to 9% compared with 2013 results excluding certain one-time items. The Company expects that growth in diluted EPS for 2014 will accelerate over the course of the year, due to a number of timing factors including the impact of recent acquisitions. Guidance for 2014 diluted EPS attributable to Henry Schein, Inc. is for current continuing operations as well as completed or previously announced acquisitions, and does not include the impact of potential future acquisitions, if any. Fourth Quarter Conference Call Webcast The Company will hold a conference call to discuss fourth quarter financial results today, beginning at 10:00 a.m. Eastern time. Individual investors are invited to listen to the conference call over the Internet through Henry Schein's website at www.henryschein.com. In addition, a replay will be available beginning shortly after the call has ended.
Zahn Dental, the Laboratory Division of Henry Schein, Inc., was recently named the preferred laboratory consumables partner for OPT-In Laboratory Cooperative by OPT-In Management, LLC. Zahn Dental...See more joins BEGO USA, Dental Wings and LabStar Software (formerly, Soundtrack) as a key corporate member in OPT-In’s strategic growth. “Working with OPT-In Dental Laboratory Cooperative helps us more effectively reach a market that has always been important to us,” said Rita Acquafredda, General Manager and Vice President, Zahn Dental. “With this partnership, we can more easily provide business support that will help small laboratories operating under the OPT-In brand become more profitable. We are thrilled to be working in support of OPT-In and to hold a strategic position amongst their current list of corporate partners.” As a strategic partner, Zahn will provide consumables and business support to laboratories operating under the OPT-In Brand. “Zahn’s position within our corporate partner network brings us closer to completing the OPT-In vision of an industry working together to serve the common good.” said Dr. Dean Mersky, President, OPT-In Management, LLC.
Shareholders in Delcam, one of the world’s leading suppliers of advanced software for manufacturing industry, today voted to accept the offer made by Autodesk to acquire the company. The acquisition...See more is expected to be completed during February. Headquartered in Birmingham, UK, Delcam has more than 30 offices worldwide and over 700 employees. The company’s range of design, manufacturing and inspection software provides automated CAD/CAM solutions for a variety of industries, ranging from automotive and aerospace to footwear and healthcare. The latest NC Software Market Analysis Report from leading US analysts CIMdata showed that, in 2012, Delcam again had the highest vendor revenues and received the highest end-user payments of all the CAM-centric companies. This result meant that the company completed thirteen years as the world’s leading specialist supplier of CAM software and services. Autodesk and Delcam offer complementary ranges of software, with Autodesk’s programs for design, engineering and entertainment able to be combined with Delcam strengths in manufacturing. On completion of the acquisition, Delcam will become a subsidiary of Autodesk. It will maintain its focus on accelerating the growth of its market share in the manufacturing sector, with the added strength that will come from being part of a larger organisation. Delcam customers will continue to be supported by the skilled and experienced engineers for which the company is renowned through its global network of Subsidiaries, Joint Ventures and Sales Partners.
The 22nd annual meeting of the European Association of Osseointegration (EAO), October 17-19, 2013, served as the platform for Nobel Biocare to launch several new innovative solutions, each focused on...See more improving patient treatment outcomes while increasing efficiency for both clinicians and laboratories. At the Convention Center Dublin, Ireland, Nobel Biocare showcased products and services which further highlight the company's commitment to leading innovation. All of the solutions presented will play important roles in Nobel Biocare's upcoming new seamless and fully integrated digital treatment workflow. New NobelProcera® 2G System gives laboratories the opportunity to build their business Reducing the time required for scanning by up to 50%, and with no compromise on precision, the new NobelProcera 2G System now offers dental labs multiple benefits at a level that can help them to grow their business. From single teeth to complex edentulous cases, the NobelProcera 2G System's increased automation capabilities and simplified workflows reduce the need for user interaction to a bare minimum, allowing dental technicians to focus on other tasks while scanning takes place, increasing the productivity of the lab. The NobelProcera 2G System can also now help labs to become more valued treatment partners. The new 2G scanner's solid model scanning capability allows for the production of highly precise digitized model surface information. This can inform the clinician's diagnostic process, involving the lab at an early stage in the treatment program, providing the opportunity to discuss restorative options for an optimum esthetic outcome. Nobel Biocare is running an exchange program which makes it easy to upgrade to the NobelProcera 2G System. Interested customers should contact their local Nobel Biocare representative today. New 'open access' gives 3Shape® customers the outstanding quality of NobelProcera® Abutments The industry-leading customized abutments from NobelProcera are now available for users of the 3Shape Dental System. After integrating with NobelProcera, 3Shape users can access the extensive global production network of NobelProcera to produce high-quality NobelProcera Abutments in zirconia and titanium for both Nobel Biocare and other major implant systems. Interested 3Shape users should contact their local Nobel Biocare representative. Availability may depend on the version in use and which 3Shape Partner has provided the Dental System. Learn more about the NobelProcera 2G System and open access at: nobelbiocare.com/nobelprocera Fully integrated digital workflow moves a step closer with NobelClinician™ Software and OsseoCare™ Pro iPad®-powered drill unit now connected The digital link that has now been established between the NobelClinician Software and the iPad-powered OsseoCare Pro drill unit will support optimal patient treatment, treatment file management and greater efficiency. Thanks to the new connection, users of the NobelClinician Software can now digitally transfer a surgery planned in NobelClinician to the intelligent OsseoCare Pro drill unit via Nobel Biocare's cloud-based network NobelConnect. The chosen implants in the correct positions and with the required drilling protocol are transferred to the OsseoCare Pro drill unit at little more than the press of a button. A patient-specific post-surgery report is now also sent straight from the OsseoCare Pro back to NobelClinician once the procedure is complete, significantly increasing the efficiency of implant placement. This new connection is an important link within Nobel Biocare's fully integrated digital treatment workflow which will become fully connected in 2014. Once in place, the full digital workflow will significantly increase predictability, efficiency and the quality of patient care at every step of the treatment process. Learn more about NobelClinician Software and OsseoCare Pro at: nobelbiocare.com/nobelclinician or nobelbiocare.com/osseocare